Targeted inactivation of the type VII collagen gene (Col7a1) in mice results in severe blistering phenotype: a model for recessive dystrophic epidermolysis bullosa

Citation
S. Heinonen et al., Targeted inactivation of the type VII collagen gene (Col7a1) in mice results in severe blistering phenotype: a model for recessive dystrophic epidermolysis bullosa, J CELL SCI, 112(21), 1999, pp. 3641-3648
Citations number
36
Categorie Soggetti
Cell & Developmental Biology
Journal title
JOURNAL OF CELL SCIENCE
ISSN journal
00219533 → ACNP
Volume
112
Issue
21
Year of publication
1999
Pages
3641 - 3648
Database
ISI
SICI code
0021-9533(199911)112:21<3641:TIOTTV>2.0.ZU;2-M
Abstract
Dystrophic forms of epidermolysis bullosa (DEB) are associated with mutatio ns in the type VII collagen gene (Col7a1) which encodes the major component of anchoring fibrils, To develop a DEB animal model, type VII collagen def icient mice were generated by targeted homologous recombination, The target ing vector replaced exons 46-69 of Col7a1 with the neomycin-resistance gene , in reverse transcriptional orientation, resulting in elimination of most of the collagenous domain 1. Col7a1 heterozygous (+/-) mice were phenotypic ally normal. Mating of Col7a1 +/- mice revealed that Col7a1 null (-/-) mice , which were born with extensive cutaneous blistering, died during the firs t two weeks of life probably due to complications arising from the blisteri ng. Transmission electron microscopy revealed subepidermal blistering below the lamina densa and absence of anchoring fibrils. Immunohistochemical sta ining with anti-human type VII collagen antibody stained the dermal-epiderm al junction in control mice, but did not stain the skin of Col7a1 null mice . Collectively, the DEB mice recapitulate the clinical, genetic, immunohist ochemical and ultrastructural characteristics of recessive DEB in humans. T hese mice provide an animal model to study the pathomechanisms of DEB and s erve as a system to test therapeutic approaches, including gene replacement , towards the cure of this devastating skin disease.